Geron
GERN
#6742
Rank
NZ$1.40 B
Marketcap
NZ$2.18
Share price
0.41%
Change (1 day)
-10.13%
Change (1 year)

Earnings for Geron (GERN)

Earnings in 2026 (TTM): -NZ$64.83 Million

According to Geron's latest financial reports the company's current earnings are NZ$0.20 Billion. In 2025 the company made an earning of -NZ$90.6 Million, an increase over its 2024 earnings that were of -NZ$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Geron from 1996 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$64.83 Million-28.45%
2025 -NZ$90.6 Million-67.42%
2024 -NZ$0.28 Billion-11.23%
2023 -NZ$0.32 Billion30.22%
2022 -NZ$0.25 Billion20.15%
2021 -NZ$0.21 Billion50.08%
2020 -NZ$0.14 Billion4.46%
2019 -NZ$0.13 Billion130.68%
2018 -NZ$55.37 Million8.84%
2017 -NZ$50.87 Million-3.08%
2016 -NZ$52.49 Million-22080.6%
2015 NZ$0.23 M-100.38%
2014 -NZ$63.42 Million-7.14%
2013 -NZ$68.29 Million
2011 -NZ$0.17 Billion19.04%
2010 -NZ$0.14 Billion8.45%
2009 -NZ$0.13 Billion-2.51%
2008 -NZ$0.13 Billion14.65%
2007 -NZ$0.12 Billion32.68%
2006 -NZ$84.4 Million25.59%
2005 -NZ$67.2 Million4.36%
2004 -NZ$64.39 Million19.73%
2003 -NZ$53.78 Million-15.46%
2002 -NZ$63.62 Million1.94%
2001 -NZ$62.41 Million33.59%
2000 -NZ$46.71 Million27.53%
1999 -NZ$36.63 Million63.13%
1998 -NZ$22.46 Million15.6%
1997 -NZ$19.43 Million-10.66%
1996 -NZ$21.74 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
-NZ$3.49 Billion 5,130.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$3.50 B-5,363.42%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-NZ$0.13 Billion 85.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.44 B-769.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-NZ$29.44 Million-55.80%๐Ÿ‡บ๐Ÿ‡ธ USA